Emerging infectious diseases · 2025
Powassan and Eastern Equine Encephalitis Virus Seroprevalence in Endemic Areas, United States, 2019-2020.
СтатьяИсторическая статьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Padda Hannah, Huang Claire Y-H, Grimm Kacie, Biggerstaff Brad J, Ledermann Jeremy P, Raetz Janae, Boroughs Karen, Mossel Eric C, Martin Stacey W, Lehman Jennifer A, Townsend Rebecca L, Krysztof David, Saá Paula, Dinh Emily T N, Stobierski Mary Grace, Esponda-Morrison Brenda, Wolujewicz Karen Ann A, Osborne Matthew, Brown Catherine M, Hopkins Brandi, Schiffman Elizabeth K, Garvin Alex, Lee Xia, Osborn Rebecca A, Wozniak Ryan J, Brault Aaron C, Basavaraju Sridhar V, Stramer Susan L, Staples J Erin, Gould Carolyn V
Аннотация
Powassan virus (POWV) and Eastern equine encephalitis virus (EEEV) are regionally endemic arboviruses in the United States that can cause neuroinvasive disease and death. Recent identification of EEEV transmission through organ transplantation and POWV transmission through blood transfusion have increased concerns about infection risk. After historically high numbers of cases of both viruses were reported in 2019, we conducted a seroprevalence survey using blood donation samples from selected endemic counties. Specimens were screened for virus-specific neutralizing antibodies, and population seroprevalence was estimated using weights calibrated to county population census data. For POWV, median county seroprevalence in 4 states was 0.84%, ranging from 0% (95% CI 0%-2.28%) to 11.5% (95% CI 0.82%-40.9%). EEEV infection was identified in a single county (estimated seroprevalence 1.62% [95% CI 0.04%-8.75%]). Although seroprevalence estimates in sampled areas were generally low, additional investigation of higher-prevalence areas could inform risk for transmission from asymptomatic blood and organ donors.